EpimAb Biotherapeutics
EpimAb Biotherapeutics is a bi-specific Antibodies founded in 2015 by Chengbin Wu.
2
Funding Rounds
$99.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ch****** Wu | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Vi**** To** | - | - | linkedin twitter instagram |
Funding series
Funding Series Analysis
The company EpimAb Biotherapeutics has raised a total of $74m in funding over 2 rounds.
Key Insights:
- EpimAb Biotherapeutics Series B round, June 2019: $74m
- EpimAb Biotherapeutics funding round, April 2017: $25m
EpimAb Biotherapeutics Series B round, June 2019
$74m
EpimAb Biotherapeutics funding round, April 2017
$25m
Industries
EpimAb Biotherapeutics is active in the following industries:
- Biotechnology
- Engineering
- Technology
- Biomedical engineering
- Biology